Actilyse

Actilyse (Alteplase) is a recombinant tissue plasminogen activator used for clot dissolution. This intravenous medication is manufactured by Boehringer Ingelheim Pharma GmbH & Co. KG and is commonly used in emergency settings.

Actilyse is primarily used to dissolve blood clots in conditions like stroke or heart attack. It works by breaking down fibrin, a key component of blood clots, to restore blood flow. This medication is often administered in emergency situations where rapid clot dissolution is critical.

Actilyse may cause common side effects such as bleeding, bruising, or allergic reactions. Some patients might experience dizziness or low blood pressure. It is important to monitor for signs of bleeding, as this is a common effect of clot-dissolving medications.

Actilyse should be handled with care due to its potent effects. It is crucial to follow medical guidelines for administration and monitoring. Patients with a history of bleeding disorders or recent surgery should use this medication with caution.

Actilyse may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Actilyse.